Detalhe da pesquisa
1.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081848
2.
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
JAMA
; 331(13): 1135-1144, 2024 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563834
3.
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Lancet Oncol
; 24(8): e331-e343, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541279
4.
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG).
Oncologist
; 28(10): e877-e883, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310797
5.
Delta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab.
Acta Oncol
; 60(4): 475-481, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191817
6.
A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns.
Breast Cancer Res Treat
; 182(3): 643-654, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524352
7.
Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence - a systematic review and meta-analysis.
Eur J Clin Pharmacol
; 76(9): 1199-1211, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504183
8.
Immune gene expression and response to chemotherapy in advanced breast cancer.
Br J Cancer
; 118(4): 480-488, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370583
9.
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.
Breast Cancer Res Treat
; 168(2): 349-355, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29190004
10.
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Mod Pathol
; 30(4): 509-518, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28084333
11.
Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.
Clin Proteomics
; 12(1): 8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25878567
12.
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden.
Pharmacoecon Open
; 8(2): 277-289, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38093030
13.
Compliance to adjuvant endocrine therapy and survival in breast cancer patients.
Cancer Treat Res Commun
; 35: 100704, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031604
14.
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study.
BMJ Open
; 13(12): e078023, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070906
15.
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
J Clin Oncol
; 41(33): 5118-5130, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556775
16.
Vascular endothelial growth factor receptor 2 and downstream p38 mitogen-activated protein kinase are possible candidate markers of intrinsic resistance to adjuvant endocrine treatment in steroid receptor positive breast cancer.
Breast Cancer Res Treat
; 125(2): 457-65, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21110084
17.
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer.
Acta Oncol
; 50(1): 35-41, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21174610
18.
Breaking Bad News in Cancer Care: Ethiopian Patients Want More Information Than What Family and the Public Want Them to Have.
JCO Glob Oncol
; 7: 1341-1348, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491813
19.
Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors.
Sci Rep
; 11(1): 23548, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876602
20.
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.
NPJ Breast Cancer
; 7(1): 98, 2021 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312396